(FINalternatives) Alex Denner’s activist hedge fund Sarissa Capital Management is seeking a sharp reduction in the compensation of Innoviva’s chief executive Michael Aguiar, the latest salvo by the investment manager in its proxy fight against the drug company.
Activist investor Sarissa Takes Aim At Innoviva CEO Compensation
This entry was posted in Syndicated. Bookmark the permalink.
